1C0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celyad Oncology SA

Watchlist Manager

Watchlist

Price: 0.25 EUR -13.19% Market Closed

Market Cap: €48.4m

C	Celyad Oncology SA SWB:1C0	BE
B	Bank of America Corp XHAN:NCB	US
	Hexaom SA PAR:ALHEX	FR
E	Edil San Felice SpA Societa Benefit F:T4M	IT
	Molson Coors Beverage Co NYSE:TAP	US
N	National Bank of Greece SA F:NAGF	GR
	Greenply Industries Ltd BSE:526797	IN
	Voltage Metals Corp OTC:VLTMF	CA
	Kirin Holdings Co Ltd TSE:2503	JP
	Aucnet Inc TSE:3964	JP
M	Meta Financial Group Inc F:FM7	US
	Technip Energies NV OTC:THNPF	FR
	BKW AG SIX:BKW	CH

Profitability Summary

Celyad Oncology SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

67%

Negative Operating Margin

-6 852%

Negative 3Y Average Operating Margin

-6 729%

Operating Margin is Increasing

-69 386% > -6 852%

Exceptional Net Margin

3 952%

Negative 3Y Average Net Margin

-4 340%

Net Margin is Increasing

-69 589% > 3 952%

Negative Free Cash Flow Margin

-32 857%

Negative 3Y Average Free Cash Flow Margin

-13 850%

Free Cash Flow Margin is Increasing

-46 361% > -32 857%

Exceptional ROE

56%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-125%

ROIC is Increasing

-132% > -44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.